$225 Million Private Placement Secured By Pioneering Drug Company

Cogent Biosciences Announces Oversubscribed $225 Million Private Placement.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In an unprecedented move within the biotech industry, Cogent Biosciences (NASDAQ: COGT) recently announced an oversubscribed private placement worth $225 million, surpassing initial expectations and signaling …